- Home
- GOSS vs AKA Comparison
GOSS vs AKA Comparison
Compare GOSS & AKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- AKA
- Stock Information
- Founded
- GOSS 2015
- AKA 2018
- Country
- GOSS United States
- AKA United States
- Employees
- GOSS 135
- AKA N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- AKA Catalog/Specialty Distribution
- Sector
- GOSS Health Care
- AKA Consumer Discretionary
- Exchange
- GOSS Nasdaq
- AKA Nasdaq
- Market Cap
- GOSS 214.7M
- AKA 251.5M
- IPO Year
- GOSS 2019
- AKA 2021
- Fundamental
- Price
- GOSS $0.97
- AKA $23.20
- Analyst Decision
- GOSS Strong Buy
- AKA Buy
- Analyst Count
- GOSS 5
- AKA 4
- Target Price
- GOSS $9.20
- AKA $18.75
- AVG Volume (30 Days)
- GOSS 942.3K
- AKA 9.9K
- Earning Date
- GOSS 11-07-2024
- AKA 11-06-2024
- Dividend Yield
- GOSS N/A
- AKA N/A
- EPS Growth
- GOSS N/A
- AKA N/A
- EPS
- GOSS N/A
- AKA N/A
- Revenue
- GOSS $95,842,000.00
- AKA $555,516,000.00
- Revenue This Year
- GOSS N/A
- AKA $4.07
- Revenue Next Year
- GOSS N/A
- AKA $3.86
- P/E Ratio
- GOSS N/A
- AKA N/A
- Revenue Growth
- GOSS N/A
- AKA N/A
- 52 Week Low
- GOSS $0.45
- AKA $5.01
- 52 Week High
- GOSS $1.60
- AKA $33.73
- Technical
- Relative Strength Index (RSI)
- GOSS 48.28
- AKA 52.84
- Support Level
- GOSS $0.98
- AKA $17.20
- Resistance Level
- GOSS $1.09
- AKA $24.40
- Average True Range (ATR)
- GOSS 0.06
- AKA 1.90
- MACD
- GOSS -0.01
- AKA -0.10
- Stochastic Oscillator
- GOSS 21.83
- AKA 65.43
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About AKA a.k.a. Brands Holding Corp.
a.k.a. Brands Holding Corp is an online fashion retailer focused on acquiring and accelerating the growth of next-generation, digitally native fashion brands targeting Gen Z and Millennial customers. The brands of the company are two women's brands, Princess Polly and Petal & Pup, and two streetwear brands, Culture Kings and mnml. The company derives maximum revenue from Australia/New Zealand.